SCHEMBL4150976

SCHEMBL4150976

CN(C(=O)NC(=O)c1c(F)cccc1F)c1ccc(SC(F)(F)F)cc1Cl

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 2/20 0.39
KMT2A Q03164 2/20 0.39
RORC P51449 3/20 0.39
TLR7 Q9NYK1 4/20 0.38
MAPT P10636 2/20 0.37
USP2 O75604 1/20 0.37
ALOX15 P16050 1/20 0.37
POLB P06746 2/20 0.37
GAA P10253 4/20 0.36
IL2 P60568 1/20 0.36
RAB9A P51151 1/20 0.35
NPSR1 Q6W5P4 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
TLR8 Q9NR97 2/20 0.35
LMNA P02545 1/20 0.34
FSCN1 Q16658 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4148202 0.91 RORC (0.38) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4158996 0.91 TRPA1 (0.34) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4154004 0.90 TLR7 (0.42) RORCTLR7MAPTPOLBGAA
SCHEMBL4150885 0.89 MEN1 (0.39) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4150857 0.89 RORC (0.36) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4149982 0.88 RORC (0.38) RORCTLR7MAPTPOLBGAA
SCHEMBL4142542 0.86 ATM (0.42) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4150579 0.82 TLR7 (0.39) MEN1KMT2ATLR7GAARAB9A
SCHEMBL4151007 0.82 TRPA1 (0.33) MEN1KMT2ARORCTLR7MAPT
SCHEMBL4636792 0.82 CYP11B1 (0.35) MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
US-20090176786-A1 Benzoylurea Compounds and Use Thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2009-07-09 US disclosed
EP-1937629-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF Sumitomo Chemical Company, Limited (JP) 2008-07-02 EP disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed
WO-2007046513-A2 BENZOYLUREA COMPOUNDS AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-04-26 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090176786-A1 Benzoylurea Compounds and Use Thereof BTK, BRIX1, NFXL1 MEN1 1863/4885KMT2A 738/4885RORC 4448/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.